Comparison Chart VISEN Pharmaceuticals

Stocks

2561

KYG93Y5D1039

Biotechnology & Medical Research

Market Closed - Hong Kong S.E. Other stock markets 04:08:11 2026-07-17 EDT			5-day change	1st Jan Change
19.20 ^HKD	-2.09%		-5.23%	-41.46%

06-26	VISEN Pharmaceuticals Announces Board Appointments, Effective June 26, 2026	CI
05-17	VISEN Pharmaceuticals commences an Equity Buyback Plan for 11,392,686 shares, representing 10% of its issued share capital, under the authorization approved on June 27, 2025.	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VISEN PHARMACEUTICALS	Other Biotechnology & Medical Research	-2.09%	-5.23%	-41.46%	-59.75%	-	267M